Page results
-
Diasend is being upgraded to Glooko. The children and young people's diabetes team at UCLH will be switching on Friday 12 August.
-
We would like to hear your views on how we could improve NHS maternity, neonatal, children and young people’s services in north central London (NCL).
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Since moving to the Grafton Way Building in April 2021, a new model of care has significantly helped the orthopaedics team
-
Almost two-thirds of intensive care staff may have experienced a mental health disorder during the Covid-19 winter surge last year, and a similar proportion said their ability to do their job was impaired because of the state of their mental health, according to a study at UCLH.
-
People suffering from long COVID may face an increased risk of abnormal blood clotting, according to a study at UCLH and UCL.
-
Five UCLH consultants have been elected Fellows of the Academy of Medical Sciences in recognition of their exceptional contributions to biomedical and health science and their ability to generate new knowledge and improve the health of people everywhere.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
The UCLH Charity Cancer Fund is launching a new campaign to refresh and update the radiotherapy department at University College Hospital.
File results
-
FOI/2023/0462 - Patients to hotels
-
FOI/2023/0457 - Psychiatric/ behavioural problems linked to psychiatric disorders use of force policies
-
FOI/2024/0236 - Proton Beam Therapy Centre
-
FOI/2019/97 Junior doctors contract
-
FOI/2019/125 Software tools used to administer meetings
-
FOI/2019/160 Retinopathy of prematurity Trust protocol
-
FOI/2019/188 Process Automation and PEPPOL
-
FOI/2019/484 Homless patients admitted to ED
-
FOI/2019/516 TMS and SCS protocols, guidelines and treatment pathways
-
FOI/2019/514 Benchmarking tool